New York State Teachers Retirement System Has $1.48 Million Holdings in R1 RCM Inc. (NASDAQ:RCM)

New York State Teachers Retirement System lifted its stake in shares of R1 RCM Inc. (NASDAQ:RCM) by 2.4% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 139,921 shares of the healthcare provider’s stock after buying an additional 3,300 shares during the quarter. New York State Teachers Retirement System’s holdings in R1 RCM were worth $1,479,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds also recently modified their holdings of the company. Vanguard Group Inc. boosted its stake in R1 RCM by 5.6% during the third quarter. Vanguard Group Inc. now owns 17,940,792 shares of the healthcare provider’s stock worth $270,368,000 after acquiring an additional 947,310 shares in the last quarter. Bank of New York Mellon Corp boosted its position in shares of R1 RCM by 3.4% during the 3rd quarter. Bank of New York Mellon Corp now owns 7,017,700 shares of the healthcare provider’s stock worth $105,757,000 after purchasing an additional 229,104 shares in the last quarter. Wellington Management Group LLP boosted its position in shares of R1 RCM by 21.1% during the 1st quarter. Wellington Management Group LLP now owns 6,223,742 shares of the healthcare provider’s stock worth $166,548,000 after purchasing an additional 1,086,266 shares in the last quarter. Invesco Ltd. grew its stake in shares of R1 RCM by 4.4% in the 3rd quarter. Invesco Ltd. now owns 5,120,817 shares of the healthcare provider’s stock valued at $77,171,000 after buying an additional 218,100 shares during the period. Finally, State Street Corp raised its stake in R1 RCM by 3.1% during the 1st quarter. State Street Corp now owns 4,915,311 shares of the healthcare provider’s stock worth $73,730,000 after buying an additional 147,840 shares during the period. Institutional investors own 61.10% of the company’s stock.

R1 RCM Trading Down 0.5 %

RCM stock opened at $12.15 on Thursday. The company has a debt-to-equity ratio of 0.57, a current ratio of 1.83 and a quick ratio of 1.83. The stock’s fifty day simple moving average is $12.67 and its two-hundred day simple moving average is $11.55. R1 RCM Inc. has a 1-year low of $8.87 and a 1-year high of $18.70.

Insider Transactions at R1 RCM

In other R1 RCM news, President John M. Sparby sold 10,046 shares of R1 RCM stock in a transaction dated Thursday, March 7th. The shares were sold at an average price of $14.33, for a total value of $143,959.18. Following the sale, the president now owns 265,986 shares of the company’s stock, valued at $3,811,579.38. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Company insiders own 37.00% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have commented on the company. Morgan Stanley reissued an “overweight” rating and issued a $17.00 price objective on shares of R1 RCM in a research note on Tuesday, March 26th. SVB Leerink began coverage on shares of R1 RCM in a research note on Monday, February 26th. They set an “outperform” rating and a $14.00 price target for the company. Guggenheim dropped their price objective on shares of R1 RCM from $17.00 to $15.00 and set a “buy” rating on the stock in a research note on Friday, April 5th. Canaccord Genuity Group decreased their target price on shares of R1 RCM from $17.00 to $16.00 and set a “buy” rating for the company in a research report on Wednesday, March 20th. Finally, Cantor Fitzgerald restated an “overweight” rating and issued a $20.00 target price on shares of R1 RCM in a report on Wednesday, April 10th. Five equities research analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $16.87.

About R1 RCM

R1 RCM Inc provides technology-driven solutions for the financial performance and patient experience of health systems, hospitals, and physician groups. It provides operating partnership/end-to-end solutions, which manages multiple aspects of the revenue cycle to realize financial leverage and revenue improvement for hospital and physician customers.